Jean-Claude Gautier

Title: The Innovative Mind of Jean-Claude Gautier

Introduction

Jean-Claude Gautier is a prominent inventor based in Clapiers, France, known for his significant contributions to pharmaceutical compositions. With a total of five patents to his name, Gautier has made strides in the field of antiarrhythmic medications, particularly through the development of innovative formulations that enhance drug delivery and effectiveness.

Latest Patents

Among his latest patents is a groundbreaking pharmaceutical composition and dosage form comprising dronedarone. This invention focuses on an oral administration method featuring a benzofuran derivative known for its antiarrhythmic properties, specifically dronedarone and its pharmaceutically acceptable salts. The composition is notably designed to be delivered in a unit dosage form, such as hard-shell capsules, aiming to minimize the meal time effect on drug absorption in humans. The inclusion of a lipid carrier in this formulation serves dual purposes: it facilitates the solubilization of the active ingredient and protects it from the detrimental effects of pH levels in the intestinal tract. This innovative approach significantly mitigates the meal effect, leading to improved therapeutic outcomes.

Furthermore, Gautier's patent for solid pharmaceutical compositions containing benzofuran derivatives also showcases his commitment to advancing drug delivery systems. This patent describes a novel solid formulation suitable for oral administration, which includes a benzofuran derivative or its pharmaceutically acceptable salts as the active ingredient, combined with a nonionic hydrophilic surfactant and other pharmaceutical excipients.

Career Highlights

Jean-Claude Gautier has garnered experience and insight through his work at notable companies in the pharmaceutical industry, including Sanofi and Sanofi-Synthelabo. Throughout his career, he has focused on enhancing drug formulations, contributing his expertise to the development of effective therapeutic solutions.

Collaborations

During his professional journey, Gautier has collaborated with esteemed colleagues, including Bernard Abramovici and Jean-Claude Gromenil. These collaborations have undoubtedly enriched his research and innovations, fostering an environment of shared knowledge and expertise.

Conclusion

Jean-Claude Gautier's contributions to pharmaceutical innovation are impactful, particularly in the realm of antiarrhythmic medications. His latest patents reflect a dedication to improving drug efficacy and patient outcomes through innovative formulations. As an inventor, Gautier continues to push the boundaries of pharmaceutical science, paving the way for future advancements in healthcare.